Insulin Resistance Is Associated with Increased Serum Levels of Glycosylphosphatidylinositol-Specific Phospholipase D

Metabolism: Clinical and Experimental

Volumn 53, Issue 2, 2004, Pages 138-139

  Kurtz, Trisha A ^b   Fineberg, Naomi S ^b   Considine, Robert V ^b   Deeg, Mark A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; C REACTIVE PROTEIN; CHOLESTEROL; GLYCOSYLPHOSPHATIDYLINOSITOL; GLYCOSYLPHOSPHATIDYLINOSITOL SPECIFIC PHOSPHOLIPASE D; HIGH DENSITY LIPOPROTEIN; INSULIN; PHOSPHOLIPASE D; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL;

EID: 0842306341     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.09.004     Document Type: Article

References (13)

1. Deeg MA, Bierman EL, Cheung MC: GPI-specific phospholipase D associates with an apo A-I and apo A-IV-containing complex. J Lipid Res 42:442-451, 2001
2. Rhode H, Schulze M, Cumme GA, et al: Glycosylphosphatidylinositol-specific phospholipase D of human serum-Activity modulation by naturally occurring amphiphiles. Biol Chem 381:471-485, 2000
3. O'Brien KD, Pineda C, Chiu WS, et al: Glycosylphosphatidylinositol-specific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes. Circulation 99:2876-2882, 1999
4. Maguire GA, Gossner A: Glycosylphosphatidylinositol phospholipase D activity in human serum. Ann Clin Biochem 32:74-78, 1995
5. Rhode H, Lopatta E, Schulze M, et al: Glycosylphosphatidylinositol-specific phospholipase D in blood serum: Is liver the only source of the enzyme? Clin Chim Acta 281:127-145, 1999
6. Raymond FD, Fortunato G, Moss DW, et al: Inositol-specific phospholipase D activity in health and disease. Clin Sci (Colch) 86:447-451, 1994
7. O'Brien T, Nguyen TT, Hallaway, et al: HDL subparticles and coronary artery disease in NIDDM. Atherosclerosis 121:285-291, 1996
8. Contiero E, Ferrari R, Vaselli GM, et al: Quantification or apolipoprotein Al-containing lipoprotein particles in noninsulin-dependent diabetes mellitus. Diabetes Res Clin Pract 39:201-209, 1998
9. Bowen RF, Raikwar, Olson LK, et al: Glucose and insulin regulate GPI-specific phospholipase D expression in islet β cells. Metabolism 50:1489-1492, 2001
10. Deeg MA, Bowen RF, Williams MD, et al: Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes. Am J Physiol Endocrinol Metab 281:E147-154, 2001
11. Du X, Low MG: Down-regulation of glycosylphosphatidylinositol-specific phospholipase D induced by lipopolysaccharide and oxidative stress in murine monocyte-macrophage cell line RAW 264.7. Infect Immun 69:3214-3223, 2001
12. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
13. Mather KJ, Hunt AE, Steinberg HO, et al: Repeatability characteristics of simple indices of insulin resistance: Implications for research applications. J Clin Endocrinol Metab 86:5457-5464, 2001